Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

120 results about "Blood parameters" patented technology

The blood parameters comprise measurements of blood cells, iron turn-over, blood coagulation, organ stress, metabolism, acute phase reactants, Common crawl. RAAM, a biological profile with the most important blood parameters will be established (Hemoglobin, hematocrit, blood volume, reticulocytes).

Systems and methods of monitoring a patient through frequency-domain photo migration spectroscopy

FDPM processing provides an amplitude signal and a phase signal at a modulation frequency to improve measurement fidelity during measurement of one or more blood parameters. In an embodiment, a light source modulates light at a modulation frequency around 200 MHz to produce an amplitude and phase plethysmograph, usable to access clinical test data.
Owner:MASIMO CORP

Systems and methods for non-invasive detection and monitoring of cardiac and blood parameters

Methods and systems for long term monitoring of one or more physiological parameters such as respiration, heart rate, body temperature, electrical heart activity, blood oxygenation, blood flow velocity, blood pressure, intracranial pressure, the presence of emboli in the blood stream and electrical brain activity are provided. Data is acquired non-invasively using ambulatory data acquisition techniques.
Owner:UNIV OF WASHINGTON +1

Blood monitoring system

The present invention is directed towards apparatuses and methods for the automated measurement of blood analytes and blood parameters for bedside monitoring of patient blood chemistry. Particularly, the current invention discloses a programmable system that can automatically draw blood samples at a suitable programmable time frequency (or at predetermined timing), can automatically analyze the drawn blood samples and immediately measure and display blood parameters such as glucose levels, hematocrit levels, hemoglobin blood oxygen saturation, blood gases, lactate or any other blood parameter.
Owner:INTELLECTUAL DISCOVERY CO LTD

Wearable, programmable automated blood testing system

The present invention is a programmable, automated device for the measurement and analysis of blood analytes and blood parameters. The device components are combined in a single apparatus and either programmed to initiate automatic, periodic blood sampling or initiate automatic blood sampling via operator input. The device operates automatically to draw blood samples at suitable, programmable frequencies to analyze the drawn blood samples and obtain the desired blood readings.
Owner:GLUCON

Method and system for use in non-invasive optical measurements of blood parameters

A method and device are presented for use in non-invasive optical measurements of at least one desired characteristic of patient's blood. A condition of artificial blood kinetics is created at a measurement location in a patient's blood perfused fleshy medium and maintained for a certain time period. This condition is altered over a predetermined time interval within said certain time period so as to modulate scattering properties of blood. Optical measurements are applied to the measurement location by illuminating it with incident light beams of at least two different wavelengths in a range where the scattering properties of blood are sensitive to light radiation, detecting light responses of the medium, and generating measured data indicative of time evolutions of the light responses of the medium for said at least two different wavelengths, respectively, over at least a part of said predetermined time interval.
Owner:ORSENSE LTD

Blood parameter testing system

A substantially automatic blood parameter testing apparatus for obtaining a blood sample and determining the concentration of at least one analyte is connected to a venous or arterial access line and further comprises a pump fixedly attached to a tube originating from the vascular access point; a valve fixedly attached to the tube and located above the pump mechanism; at least one measurement element; a needleless port; and an electronic meter. In addition, the automated blood parameter testing apparatus may be integrated into a complete system, further including a monitor and a central monitoring station.
Owner:GLUCON

Blood monitoring system

The present invention is directed towards apparatuses and methods for the automated measurement of blood analytes and blood parameters for bedside monitoring of patient blood chemistry. Particularly, the current invention discloses a programmable system that can automatically draw blood samples at a suitable programmable time frequency (or at predetermined timing), can automatically analyze the drawn blood samples and immediately measure and display blood parameters such as glucose levels, hematocrit levels, hemoglobin blood oxygen saturation, blood gases, lactate or any other blood parameter.
Owner:GLUCON

Method of optical measurements for determining various parameters of the patient's blood

A method for optical measurements of desired parameters of the patient's blood is presented. A state of the blood flow cessation is provided within a measurement region and maintained during a predetermined time period. Measurement sessions are performed within this predetermined time period. Each measurement session includes at least two measurements with different wavelengths of incident light. Obtained measured data is representative of the time dependence of light response of the blood in the measurement region. The analyses of the measured data enables the determination of the desired blood parameters extracted from optical characteristics associated with the erythrocytes aggregation process during the state of the blood flow cessation.
Owner:ORSENSE LTD

Blood monitoring system

The present invention is directed towards apparatuses and methods for the automated measurement of blood analytes and blood parameters for bedside monitoring of patient blood chemistry. Particularly, the current invention discloses a programmable system that can automatically draw blood samples at a suitable programmable time frequency (or at predetermined timing), can automatically analyze the drawn blood samples and immediately measure and display blood parameters such as glucose levels, hematocrit levels, hemoglobin blood oxygen saturation, blood gases, lactate or any other blood parameter.
Owner:INTELLECTUAL DISCOVERY CO LTD

Wearable, programmable automated blood testing system

The present invention is a programmable, automated device for measurement and analysis of blood analytes and blood parameters. The device components are preferably combined in a single housing and either programmed to initiate automatic, periodic blood sampling or initiate automatic blood sampling via operator input or in response to a predefined event or in response to a signal from another instrument. The device operates automatically to draw blood samples and analyze the drawn blood samples to obtain the desired blood readings.
Owner:GLUCON

Device and method for noninvasive continuous determination of physiologic characteristics

The invention comprises devices for noninvasively monitoring physiological characteristics of a patient's blood. Generally, probes having radiation emitters and detectors are used to determine absorbance of blood within the patient's tissue to determine various blood parameters. The device also has either a position sensor for determining the position of the probe with respect to the patient's heart or a movement generator for altering the position of the probe with respect to the patient's heart. The invention also comprises methods for noninvasively monitoring the physiological characteristics. In one embodiemnt, induced positional changes create differential hydrostatic pressures to facilitate measurement of blood parameters by absorbance. In a second embodiment, delays in pulse arrival times in coupled organs or members on opposite sides of the body are measured to determine cardiac output. The two methods are such that they can advantageously be used together.
Owner:WOOLSTHORPE TECH

Test substrate handling apparatus

The present invention is an integrated, test substrate handling apparatus for the measurement and analysis of blood analytes and blood parameters. The test substrate handling apparatus includes multiple test substrate components combined in a single unit. It advances a test substrate for measurement of blood parameters via programmed, periodic blood sampling or via operator input.
Owner:GLUCON

Methods and systems for providing a nutraceutical program specific to an individual animal

The present invention relates to methods and systems for providing an animal with a nutraceutical program that is specifically tailored to address the deficiencies and / or needs of the particular animal. Blood is drawn from the animal and analyzed at a lab to obtain blood test results. The blood test results are scored to obtain at least one blood test score for at least one corresponding blood parameter. If the at least one blood test score falls within a normal range but outside of an optimal range, one or more nutraceuticals needed to bring the animal within the optimal range for the at least one corresponding blood parameter are identified. A prescribed dosage amount is then calculated for at least one of the one or more identified nutraceuticals for the animal. The calculation of the prescribed dosage amount is based on at least the blood test score for the corresponding blood parameter and a deviation of the blood test score from the optimal range.
Owner:BIONUTRITIONAL

Automated Blood Sampler and Analyzer

An automated blood sampler integratable with a glucose monitor comprises a catheter connected to a tube-set forming a single blood passageway; a clamp-on air-bubble sensor and a occlusion sensor externally attached to the tube set; a single peristaltic pump and two 3-way pinch valves attached to the tube set and control fluid flow. The sampler draws blood from a stationary patient, samples the blood for analytical measurement of blood parameters; after which the passageway is rinsed, the blood re-infused, and slow saline infusion prevents vein collapse. The cycle repeats at user or predefined intervals. In another preferred embodiment, blood is not re-infused, and only one 3-way pinch valve is used.
Owner:CASCADE METRIX LLC

Blood monitoring system

The present invention is directed towards apparatuses and methods for the automated measurement of blood analytes and blood parameters for bedside monitoring of patient blood chemistry. Particularly, the current invention discloses a programmable system that can automatically draw blood samples at a suitable programmable time frequency (or at predetermined timing), can automatically analyze the drawn blood samples and immediately measure and display blood parameters such as glucose levels, hematocrit levels, hemoglobin blood oxygen saturation, blood gases, lactate or any other blood parameter.
Owner:GLUCON

Wearable Automated Blood Sampling and Monitoring System

A wearable blood chemistry monitoring device is disclosed which comprises a wearable automated blood chemistry monitoring device comprising (A) a mini pump which can be, for example a peristaltic pump or syringe pump; (B) a portable form factor mechanical apparatus which preferably includes a rotatable disc with a hole which fits over the pump; (C) at least one measurement element for measuring at least one blood parameter, preferably on the disc, and preferably a series of glucose strips arranged radially in a spoke-like pattern on the disc; (D) a catheter connected to the pump via a tube; (E) a computerized device adapted to automatically measure blood analytes and blood parameters; (F) a belt adapted to hold the housing, a waste bag, and a flush solution bag; wherein the pump and disk are arranged in the housing so that a hole in a disk fits over the pump.
Owner:GLUCON

Blood parameter measurement device

A blood parameter measurement device especially useful for surgical procedures includes a compact housing with a light source, light detector and signal converter contained within the housing. In use, the device is releasably coupled to a cassette that can be either used as an in-line cell in series with a cardiopulmonary by-pass circuit, or in another passageway that shunts the cardiopulmonary by-pass circuit. Preferably, the housing of the device has a longitudinal axis that extends in a direction generally parallel to the direction of blood flowing through the cassette.
Owner:TERUMO CARDIOVASCULAR SYST CORP

Method for stimulating neural tissue in response to a sensed physiological event

InactiveUS20060058854A1Minimizing invasivenessHead electrodesDiseaseNervous system
A method of treating a disorder of a patient, such as a neurological disorder, is provided. The method comprises intravascularly delivering at least one of a stimulation lead and a sensing lead within the head of the patient. For example, one or both of the leads can be delivered into the patient's head via the circulatory system (e.g., vein or artery) or the ventricular system (e.g., through the intrathecal space of the spine). The method further comprises sensing a physiological event associated with the disorder (e.g., physiological electrical activity, a blood parameter, or intracranial pressure) using the sensing lead, and stimulating neural tissue with the stimulation lead in response to the sensed physiological event.
Owner:BOSTON SCI SCIMED INC

Method of optical measurements for determining various parameters of the patient's blood

A method for optical measurements of desired parameters of the patient's blood is presented. A state of the blood flow cessation is provided within a measurement region and maintained during a predetermined time period. Measurement sessions are performed within this predetermined time period. Each measurement session includes at least two measurements with different wavelengths of incident light. Obtained measured data is representative of the time dependence of light response of the blood in the measurement region. The analyses of the measured data enables the determination of the desired blood parameters extracted from optical characteristics associated with the erythrocytes aggregation process during the state of the blood flow cessation.
Owner:ORSENSE LTD

Blood treatment device and method for blood treatment

The present invention provides a blood treatment device and methods of blood treatment to provide an individual patient with the most suitable blood treatment and reduced treatment duration. Specifically, the invention provides a blood treatment device comprising a treating means 11 that treats blood collected from a patient; a measuring means 12 that measures parameters of the patient's blood and indicates blood condition; a controlling means 13 that controls the treatment procedures based upon the blood parameters; a storing means 15 that records an ideal patient-specific blood parameter curve for the treatment duration; and a directing means 14 that directs the control by the controlling means 13 so that the measured blood parameters approximate to the ideal blood parameter curve by comparing the measured blood parameters with the ideal blood parameter curve recorded by the storing means 15.
Owner:NIKKISO COMPANY

System and method to analyze blood parameters using magnetic resonance imaging

InactiveUS20100030062A1Accurate measurementClear attributionMagnetic measurementsSensorsVascular compartmentCerebral metabolic rate
A system and method for accurately producing MR images of selected vascular compartments includes employing a control scan and a tag scan, each including velocity selective modules that suppress signal from blood flowing faster than a given cutoff velocity, to acquire control and tag sets of NMR data that may be subtracted to produce a compartment-specific MR image that is substantially free of information from stationary tissues and blood outside the selective vascular compartments. Accordingly, physiological parameters, such as oxygen saturation (SaO2), oxygen extraction fraction (OEF), and cerebral metabolic rate of oxygen (CMRO2), can be generated from the compartment-specific images. Further still, kinetic curves of oxygen exchange can be created, thus providing detailed insight into oxygen exchange dynamics.
Owner:THE GENERAL HOSPITAL CORP

Method and apparatus for the management of diabetes

A biological chip device having a biologic materials component according to embodiments of the invention may provide the ability to sense levels of blood parameters (e.g., glucose, insulin, and glucagon levels) in a patient. In certain embodiments of the invention, a device may include therapeutic abilities in which a portion of the biologic materials component produces a drug to treat the underlying disease in response to measured or sensed blood parameter levels.
Owner:ROSERO SPENCER Z

Photon density wave based determination of physiological blood parameters

A method for measuring a physiological parameter of blood in a patient is presented. The method includes emitting light from a modulated light source into tissue of the patient to generate a photon density wave in the tissue, detecting the photon density wave during pulsatile perturbation of the tissue, and processing an amplitude and phase of the photon density wave over the pulsatile perturbation to determine a value of the physiological parameter.
Owner:TYCO HEALTHCARE GRP LP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products